Last CNY8.34 CNY
Change Today +0.01 / 0.12%
Volume 17.0M
600664 On Other Exchanges
Symbol
Exchange
Shanghai
As of 10:51 PM 09/23/14 All times are local (Market data is delayed by at least 15 minutes).

harbin pharmaceutical grp-a (600664) Snapshot

Open
CNY8.25
Previous Close
CNY8.33
Day High
CNY8.43
Day Low
CNY8.20
52 Week High
09/10/14 - CNY8.95
52 Week Low
02/7/14 - CNY5.57
Market Cap
16.0B
Average Volume 10 Days
34.5M
EPS TTM
CNY0.16
Shares Outstanding
1.9B
EX-Date
08/26/14
P/E TM
52.0x
Dividend
CNY0.07
Dividend Yield
0.79%
Current Stock Chart for HARBIN PHARMACEUTICAL GRP-A (600664)

Related News

No related news articles were found.

harbin pharmaceutical grp-a (600664) Related Businessweek News

No Related Businessweek News Found

harbin pharmaceutical grp-a (600664) Details

Harbin Pharmaceutical Group Co., Ltd. is engaged in the research and development, manufacture, and trading of pharmaceutical products. It offers antibiotics, small-molecular drug preparations, OTC and healthcare products, Chinese medicines, biopharmaceuticals, animal vaccines, and medicine circulations. The company’s APIs include penicillin and cephalosporin products, and other pharmaceutical intermediates in various dosage forms, such as injections, injectable powders, oral solutions, tablets, and capsules. The company markets its products primarily to Europe, Asia, Africa, and Middle and North America. Harbin Pharmaceutical Group Co., Ltd. is based in Harbin, China.

harbin pharmaceutical grp-a (600664) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

harbin pharmaceutical grp-a (600664) Key Developments

Harbin Pharmaceutical Group Co., Ltd. Announces Earnings Results for the First Half of 2014

Harbin Pharmaceutical Group Co., Ltd. announced earnings results for the first half of 2014. For the first half, the company reported basic earning per share of CNY 0.17 and weighted average return on net assets of 3.88%.

Harbin Pharmaceutical Group Co., Ltd. to Report First Half, 2014 Results on Aug 30, 2014

Harbin Pharmaceutical Group Co., Ltd. announced that they will report first half, 2014 results on Aug 30, 2014

Harbin Pharmaceutical Group Co., Ltd. Announces Cash Dividend, Payable on August 26, 2014

Harbin Pharmaceutical Group Co., Ltd. announced cash dividend (taxes included) of RMB 0.66 for every 10 shares for the year 2013, payable on August 26, 2014 to the shareholders record on August 25, 2014. Ex-dividend date is on August 26, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600664:CH CNY8.36 CNY +0.03

600664 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China BCT Pharmacy Group Inc $0.06 USD 0.00
Kirin Holdings Co Ltd ¥1,432 JPY -14.00
Roche Holding AG SFr.282.20 CHF -1.00
View Industry Companies
 

Industry Analysis

600664

Industry Average

Valuation 600664 Industry Range
Price/Earnings 52.3x
Price/Sales 0.9x
Price/Book 1.9x
Price/Cash Flow 52.6x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HARBIN PHARMACEUTICAL GRP-A, please visit www.hayao.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.